Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada

References

• Vogelmeier CF, Criner GJ, Martínez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Arch Bronconeumol. 2017;53:128–149. doi:10.1016/j.arbres.2017.02.00128274597
   PubMed Web of Science ®Google Scholar
• GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691–706. doi:10.1016/S2213-2600(17)30234-528822787
   PubMed Web of Science ®Google Scholar
• Statistics Canada. (2018). Chronic Obstructive Pulmonary Disease (COPD), 35 years and over. Table: 13-10-0096-19. 2019 Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310009619. Accessed August 21, 2018.
   Google Scholar
• Report From The Canadian Chronic Disease Surveillance System: Asthma And Chronic Obstructive Pulmonary Disease (Copd) In Canada, 2018. Public Health Agency of Canada; 2018 Available from: http://publications.gc.ca/collections/collection_2018/aspc-phac/HP35-90-2018-eng.pdf. Accessed 21 August 2018.
   Google Scholar
• Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543–1554. doi:10.1056/NEJMoa080193618836213
   PubMed Web of Science ®Google Scholar
• In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group. Chest. 1994;105:1411–1419. doi:10.1378/chest.105.5.14118181328
   PubMed Web of Science ®Google Scholar
• Gladysheva ES, Malhotra A, Owens RL. Influencing the decline of lung function in COPD: use of pharmacotherapy. Int J Chron Obstruct Pulmon Dis. 2010;5:153–164.20631815
   PubMedGoogle Scholar
• Yang IA, Brown JL, George J, et al. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update. Med J Aust. 2017;207:436–442.29129177
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;49:1600791.28298398
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53:1900164. doi:10.1183/13993003.00164-201930846476
   PubMed Web of Science ®Google Scholar
• Khakban A, Sin DD, FitzGerald JM, et al. 10-Year trends in direct costs of COPD: a population based study. Chest. 2015;148:640–646. doi:10.1378/chest.15-072126043120
   PubMed Web of Science ®Google Scholar
• Ford ES, Mannino DM, Giles WH, Wheaton AG, Liu Y, Croft JB. Prescription practices for chronic obstructive pulmonary disease: findings from the national ambulatory medical care survey 1999-2010. COPD. 2014;11:247–255.24568285
   PubMedGoogle Scholar
• Population Estimates, BC Stats, Central Statistical Agency of the Province of British Columbia. Available from:  https://www2.gov.bc.ca/gov/content/data/statistics/people-population-community/population/population-estimates. Accessed August 21, 2018.
   Google Scholar
• British Columbia Ministry of Health [creator]. Consolidation File (MSP Registration & Premium Billing). V2. Population Data BC [publisher]. Data Extract. MOH (2011); 2011 Available from: http://www.popdata.bc.ca/data. Accessed 817, 2019.
   Google Scholar
• BC Vital Statistics Agency [creator]. Vital statistics deaths. V2. Population data BC [publisher]. Data Extract BC Vital Statistics Agency (2011); 2011 Available from: http://www.popdata.bc.ca/data. Accessed 817, 2019.
   Google Scholar
• Canadian Institute for Health Information [creator]. Discharge Abstract Database (Hospital Separations). Population Data BC [publisher]. Data Extract. MOH (2014); 2014 Available from: http://www.popdata.bc.ca/data. Accessed 817, 2019.
   Google Scholar
• British Columbia Ministry of Health [creator]. Medical Services Plan (MSP) Payment Information File. V2. Population data BC [publisher]. Data Extract. MOH (2011); 2011 Available from: http://www.popdata.bc.ca/data. Accessed 817, 2019.
   Google Scholar
• BC Ministry of Health [creator]. PharmaNet. BC Ministry of Health [publisher]. Data Extract. Data Stewardship Committee (2013); 2014 Available from: http://www.popdata.bc.ca/data. Accessed 817, 2019.
   Google Scholar
• Williams J, Adger W. Inventory of Studies on the Accuracy of Canadian Health Administrative Databases. Toronto: Institute for Clinical Evaluative Sciences; 1996.
   Google Scholar
• Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD. 2009;6:388–394. doi:10.1080/1541255090314086519863368
   PubMedGoogle Scholar
• Consumer Price Index, Bank of Canada, October 2013. Available from: https://www.bankofcanada.ca/wp-content/uploads/2010/11/consumer_price_index.pdf. Accessed August 21, 2018.
   Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.16224307
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 update. Can Respir J Can Thorac Soc. 2007;14 Suppl B:5B–32B.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J Can Thorac Soc. 2008;15 Suppl A:1A–8A.
   PubMed Web of Science ®Google Scholar
• Ford ES, Mannino DM, Wheaton AG, et al. Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010. PLoS One. 2014;9:e95305. doi:10.1371/journal.pone.009530524751857
   PubMed Web of Science ®Google Scholar
• Falk J, Dik N, Bugden S. An evaluation of early medication use for COPD: a population-based cohort study. Int J Chron Obstruct Pulmon Dis. 2016;11:3101–3108. doi:10.2147/COPD.S12364327994449
   PubMed Web of Science ®Google Scholar
• Lee J, Lee JH, Kim J-A, Rhee CK. Trend of cost and utilization of COPD medication in Korea. Int J Chron Obstruct Pulmon Dis. 2017;12:27–33. doi:10.2147/COPD.S15088728031708
   PubMed Web of Science ®Google Scholar
• Blanc PD, Eisner MD, Yelin EH, et al. Socioeconomic gradients in tiotropium use among adults with COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:483–490. doi:10.2147/COPD.S331918990978
   PubMedGoogle Scholar
• Tøttenborg SS, Lange P, Johnsen SP, Nielsen H, Ingebrigtsen TS, Thomsen RW. Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD. Respir Med. 2016;119:160–167. doi:10.1016/j.rmed.2016.09.00727692139
   PubMed Web of Science ®Google Scholar
• Mueller S, Wilke T, Bechtel B, Punekar YS, Mitzner K, Virchow JC. Non-persistence and non-adherence to long-acting COPD medication therapy: a retrospective cohort study based on a large German claims dataset. Respir Med. 2017;122:1–11. doi:10.1016/j.rmed.2016.11.00827993284
   PubMed Web of Science ®Google Scholar
• Adesanoye DT, Willey CJ. Does cardiovascular comorbidity influence the prescribing of bronchodilators in chronic obstructive pulmonary disease? Ann Pharmacother. 2017;51:855–861. doi:10.1177/106002801771253128573879
   PubMed Web of Science ®Google Scholar